Wednesday - February 11, 2026
Federal Executive Branch

Here's a look at documents from the U.S. Executive Branch

Featured Stories

Smithsonian's National Zoo and Conservation Biology Institute and Royal Commission for AlUla Advance Next Phase of Global Effort To Save the Critically Endangered Arabian Leopard
WASHINGTON, Feb. 11 -- The Smithsonian Institution National Zoo and Conservation Biology Institute issued the following news release:

* * *

Smithsonian's National Zoo and Conservation Biology Institute and Royal Commission for AlUla Advance Next Phase of Global Effort To Save the Critically Endangered Arabian Leopard

With fewer than an estimated 120 Arabian leopards remaining in the wild, coordinated global action is essential to prevent the extinction of one of the world's rarest big cat species.

On Feb. 10, the International Day of the Arabian Leopard, the Smithsonian's National Zoo and Conservation ... Show Full Article

SEC Dismisses Civil Enforcement Action Against Illinois Investment Adviser and Its Minority Owner and Simultaneously Institutes Settled Administrative Proceeding
WASHINGTON, Feb. 11 -- The Securities and Exchange Commission issued the following litigation release (No. 21-cv-3450; N.D. Ill. filed June 28, 2021):

* * *

Securities and Exchange Commission v. Barrington Asset Management and Gregory D. Paris, No. 21-cv-3450 (N.D. Ill. filed June 28, 2021)

On February 10, 2026, the Securities and Exchange Commission filed a joint stipulation with Barrington Asset Management, Inc., an investment adviser located and registered in Illinois, and Gregory David Paris, a minority owner, vice president and chief compliance officer of Barrington, to dismiss, with prejudice, ... Show Full Article

NIH Halts Arm of Clinical Trial Evaluating a Potential Stroke Treatment
WASHINGTON, Feb. 11 (TNSrep) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:

* * *

NIH halts arm of clinical trial evaluating a potential stroke treatment

Study found low-dose rivaroxaban to be unsafe and ineffective compared to standard of care.

*

The National Institutes of Health (NIH) has stopped an investigational treatment arm of the Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) study (https://clinicaltrials.gov/study/NCT05047172?term=CAPTIVA&rank=2), following ... Show Full Article

FDA Issues Warning Letter to Signature Formulations
WASHINGTON, Feb. 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Signature Formulations LLC from the Center for Drug Evaluation and Research:

* * *

Recipient: Ms. Maria Esparza, President and Owner, Signature Formulations, LLC, 5446 W Roosevelt St., Ste 101, Phoenix, AZ 85043, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

Warning Letter 320-26-38

Dear Ms. Esparza:

The United States Food and Drug Administration (FDA) inspected your drug manufacturing facility, Signature ... Show Full Article

FDA Issues Warning Letter to Niqpouches.com
WASHINGTON, Feb. 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to niqpouches.com from the Center for Tobacco Products:

* * *

Recipient: niqpouches.com, Sweden, info@niqpouches.com

Issuing Office: Center for Tobacco Products, United States

January 30, 2026

WARNING LETTER

To Whom It May Concern:

The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed the website https://niqpouches.com and determined that nicotine pouch products listed there are offered for sale or distribution ... Show Full Article

FDA Issues Warning Letter to Maui Seafood
WASHINGTON, Feb. 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Maui Seafood LLC from the Human Foods Program:

* * *

Recipient: Yong J. Chang, Owner, Maui Seafood LLC, 1741 S. Mojave Rd, Las Vegas, NV 89104-4503, United States, mauiseafoodlv@gmail.com

Issuing Office: Human Foods Program, United States

WARNING LETTER

Re: CMS Case # 715844

Dear Mr. Chang:

The United States Food and Drug Administration (FDA) conducted an inspection of your ready-to-eat (RTE) seafood processing facility, located at 1741 S. Mojave Rd, ... Show Full Article

FDA Issues Warning Letter to Louisville Reproductive Center
WASHINGTON, Feb. 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Louisville Reproductive Center from the Center for Biologics Evaluation and Research:

* * *

Recipient: Dr. Miriam S. Krause, Medical Director, Louisville Reproductive Center, 4123 Dutchmans Lane, Suite 416, Louisville, KY 40207-4733, United States, Mkrause@ivfkentucky.com

Issuing Office: Center for Biologics Evaluation and Research, United States

WARNING LETTER

CBER 26-722350

Dear Dr. Krause:

During an inspection of your firm, Louisville Reproductive ... Show Full Article